2020, Number 2
Ortho-tips 2020; 16 (2)
López AL, Padilla RLG, Garín ZDE, Dittmar JM
PDF size: 202.95 Kb.
ABSTRACTIn December 2019 a new disease occurred in China that has presented a global spread. Currently affecting more than 4 million and causing the death of more than 300 thousand people. With a mortality rate that goes above 13% in several countries in Europe. Most patients have mild symptoms and a good prognosis. The most common manifestations are fever, dry cough, dyspnea, myalgia, headache, fatigue. Other findings are a decrease in lymphocytes in the blood, a high ferritin index and radiographic evidence of pneumonia, with an atypical infiltrate due to diffuse alveolar damage, believed to be an interstitial inflammation, thromboembolism. There is involvement of various organs, and in many cases disseminated intravascular coagulation (DIC), with involvement of the vascular endothelium. The stress associated with fracture and surgical treatment can generate an oxidative stress response. Increasing the expression of inflammatory factors and decreasing the patient’s immunity, increasing the risk of death from COVID-19. The objective of this document is to be a guide for the Orthopedist to care for and protect the surgical team and the patient, knowing the risks of surgical treatment, good use and management of the placement equipment and osteosynthesis material. And the surgical procedures that can be performed during this pandemic, with the aim of reducing risks of contagion and death in patients and in health workers.